Top 5 Dominating Key Players in Peripheral Artery Disease Market

Peripheral artery disease market was valued at $3,136 million in 2016, and is projected to reach $4,980 million by 2023, growing at a CAGR of 6.8% from 2017 to 2023. The peripheral stents segment held more than two-fifth share of the total market in 2016.

The introduction of new interventional treatment options such as atherectomy drives the market growth. Atherectomy is beneficial in removing the build-up of plaque in arteries with the help of stent or catheter. Thus, with the increase in prevalence of calcified and hard lesions the market for atherectomy is expected to grow.

Get sample copy of this report: https://www.alliedmarketresearch.com/request-sample/4315

Peripheral artery disease is a circulatory disease in which plaque builds up in the arteries of legs, heads, and other limbs. Increase in geriatric population and rise in number of patients suffering from peripheral artery disease, are expected to drive the market growth. Moreover, favorable reimbursement scenario for peripheral artery disease treatment and advanced peripheral treatment products such drug-eluting stents in turn boosts the market growth. However, restenosis (reoccurrence of peripheral artery disease post treatment) is expected to impede the market growth.

Peripheral stents segment is expected to dominate the market throughout the analysis period as these significantly reduce the risk associated with the build-up of plaque in the arteries. Plaque modification devices is expected to register highest CAGR of 7.6% during the forecast period.

Access full summary: https://www.alliedmarketresearch.com/peripheral-artery-disease-market

Key Findings of the Peripheral Artery Disease Market:

• Atherectomy devices is projected to grow at a CAGR of 7.9% during the forecast period.

• Chronic total occlusion devices accounted for more than two-fifth of the share of the global peripheral artery disease market, in 2016.

• Aspiration thrombectomy segment is expected to register the highest CAGR of 10.3% during the analysis period.

• Drug-eluting stents is expected to grow at the CAGR of 7.7% during the forecast period.

• France and Germany collectively contributed for more than one-third share of the European peripheral artery disease market in 2016.

• Japan is the major shareholder, accounting for more than one-third share of the Asia-Pacific peripheral artery disease market in 2016.

Asia-Pacific is projected to register the highest CAGR of 7.9% during the forecast period, owing to increase in incidence of population suffering from diabetes, obesity, and high blood pressure. In addition, increase in healthcare expenditure and introduction of interventional products such as drug-coated balloon offer a lucrative opportunity for the market growth.

Make purchase enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/4315

The major companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Cook Medical, Cardinal Health, Inc., C. R. Bard, Inc., Medtronic plc, Terumo Corporation, The Spectranetics Corporation, AngioDynamics, Inc., BIOTRONIK, and B. Braun Melsungen AG.

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

Shriram Dighe
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.